Skip to main content
. 2006 May;27(5):1019–1026.

Table 3:

Alcoholics: rank correlations of 1H-MRS, MTR, and ADC and grading of hepatic encephalopathy

Alcoholics, Mean (±SD)
Correlation (Spearman-Rho)
Controls, Mean (±SD) HE 0 mHE HE1 HE2 r P
1H-MRS, n = 34 n = 10 n = 6 n = 7 n = 5 n = 6
    Basal ganglia
        mlns/Cr** 0.784 (0.570) 0.256** (0.198) 0.260** (0.214) 0.347* (0.191) 0.296* (0.247) .03 .889
        NAA/Cr 1.670 (0.252) 1.623 (0.321) 1.453 (0.204) 1.645 (0.185) 1.559 (0.164) .03 .896
        Cho/Cr** 0.267 (0.041) 0.205** (0.032) 0.186** (0.041) 0.217 (0.053) 0.203* (0.049) .01 .980
        Glx/Cr* 1.513 (0.556) 2.079* (0.417) 2.795** (0.618) 2.597** (0.724) 2.516 (1.747) .09 .669
    Occipital lobe
        mins/Cr** 0.823 (0.099) 0.295* (0.296) 0.272** (0.191) 0.310** (0.103) 0.252** (0.158) .12 .567
        NAA/Cr 1.708 (0.175) 1.920 (0.283) 1.877* (0.118) 1.807 (0.262) 1.914 (0.365) −.11 .601
        Cho/Cr 0.258 (0.042) 0.257 (0.056) 0.225 (0.055) 0.253 (0.044) 0.226 (0.036) −.12 .572
        Glx/Cr** 1.413 (0.489) 2.071 (0.643) 2.229** (0.919) 2.774** (1.150) 2.084* (0.412) 0.00 .988
MTR (%), n = 44 n = 18 n = 7 n = 8 n = 5 n = 6
    Pons 40.1 (1.5) 39.5 (0.5) 38.4* (1.5) 38.2 (2.6) 39.1 (2.4) −.11 .600
    Thalamus** 39.4 (0.9) 39.5* (0.5) 38.4* (1.5) 38.2** (2.6) 39.1** (2.4) −.07 .730
    Pallidum** 37.1 (1.6) 37.9** (1.6) 37.6** (2.0) 37.9** (0.7) 37.6** (1.6) .01 .974
    Putamen** 35.9 (1.5) 32.1** (3.8) 29.1** (5.6) 28.7** (2.7) 32.9** (1.7) −.06 .774
    Caudate** 36.5 (2.2) 33.1 (1.7) 31.0* (2.6) 32.3** (1.3) 32.4** (2.5) −.18 .389
    Occipital lobe** 39.0 (1.5) 34.3** (4.0) 32.8** (4.1) 31.6** (2.1) 32.8** (3.6) .08 .707
ADC (10.5 mm2/s), n = 44 n = 18 n = 7 n = 8 n = 5 n = 6
    Thalamus 81.8 (4.7) 79.4 (4.1) 82.1 (5.1) 86.4* (2.6) 82.4 (7.1) .31 .121
    Occipital NAWM 93.1 (15.7) 91.9 (4.7) 86.7 (8.0) 100.2 (7.8) 93.6 (8.6) .18 .378

Note:1H-MRS indicates proton magnetic resonance spectroscopy; MTR, magnetization transfer ratio; ADC, apparent diffusion coefficient; HE, hepatic encephalopathy; mHE, minimal HE; mIns, myoinositol; Cr, creatine and phosphocreatine; NAA, N-acetylaspartate; Cho, choline-containing.

*

Significantly different from control group (P < .05, Mann-Whitney U).

**

Significantly different from control group (P < .01, Mann-Whitney U).